Neudle.com: Parkinson disease off time

Differential
(Click to cross reference)

abdominal protrusion

acromegaly

activities of daily living

adrenal medullary tissue

advances in neurology

adverse drug reaction

affect, flat

agitation

akinetic mute

alcohol, neurologic complications with

Alzheimer's disease, misdiagnosis

amantadine

amnesia

amnesia, concussion

amyotrophic lateral sclerosis

amyotrophic lateral sclerosis, familial

amyotrophic lateral sclerosis, guamian type of

amyotrophic lateral sclerosis, Parkinson-dementia-complex

anesthesia, general

aneurysm, intracranial

angiography, cerebral

animal exposure

anti basal ganglia antibodies

anti IgLON5

antibiotics, neurologic complications with

anticholinergic drugs

anticoagulant, complications of

anticoagulant, treatment

aphasia, progressive, primary

apomorphine

apraxia

apraxia of eyelid opening

apraxia, constructional

arbovirus

areflexia

arteriovenous malformation, brainstem

attention deficit disorder with hyperactivity

attention span

atypical

autoantibodies

autoimmune cerebellar ataxia

autoimmune disease

autoimmune GFAP astrocytopathy

autonomic dysfunction

Babinski sign

basal ganglia

basal ganglia, infarction

basal ganglia, lesion of

basal ganglia, lesion, bilateral

behavioral disorder

benign essential tremor

benign essential tremor, refractory

benserazide

bilirubin encephalopathy

brain transplantation

brain transplantation, complications of

brainstem, lesion of

brainstem, vascular malformation of

carbon monoxide poisoning

carcinoma

CAT scan

CAT scan, abnormal

CAT scan, angiography

CAT scan, angiography, false negative

CAT scan, emission

CAT scan, emission, abnormal

CAT scan, stereotactic localization

CAT scan, venography

catechol-o-methyltransferase inhibitor

cavernous hemangioma

central hypoventilation

centrum semiovale

cerebellar atrophy, primary

cerebellar edema

cerebellar hemorrhage

cerebellar lesion

cerebellar vermis

cerebellitis

cerebellum, disease of

cerebral autosomal dominate arteriopathy with subcortical infarction and leukoencephalopathy

cerebral cortical atrophy

cerebral infarction

cerebrospinal fluid

cerebrospinal fluid, abnormal

cerebrospinal fluid, elevated protein of

cerebrovascular accident

cerebrovascular accident, complications with

ceruloplasmin, serum

chemotherapy, CNS treatment and complications with

chromosomal abnormality

chromosome 14

chromosome 17

cingulate island sign

cirrhosis

climate change

Clinical Pathologic Conference(C.P.C.)

computers, medicine and

controversies in neurology

conversion reaction

copper metabolism, abnormal

coprolalia

corpus callosum, lesion of

corpus callosum, thinning

cortical-basal ganglionic degeneration

cost effectiveness

cough

CPAP

cranial nerve palsies

cranial neuropathy

creatine phosphokinase(CPK)elevated

Cushing's syndrome

DATATOP study

deep gray nuclei

degenerative diseases of CNS

delay in diagnosis

delusion

dementia

dementia, age at onset

dementia, familial

dementia, frontal lobe type

dementia, frontotemporal

dementia, posttraumatic

dementia, presenile

dementia, rapidly progressive

dementia, thalamic

demyelinating disease

deprenyl

depression

developmental milestones, loss of

developmental retardation

developmental venous anomalies

dexamethasone suppression test

dexterity, impaired

diabetes dialysis basal ganglia syndrome

diabetes mellitus

diabetes mellitus, neurologic manifestations of

diagnostic criteria

dialysis

diet

differential diagnosis

diplopia

disability rating scale, neurological

disability, neurological

disorientation

distal muscle atrophy

diurnal variation

dizziness

dopa responsive dystonia

dopamine agonist

dopamine agonist withdrawal syndrome

dopamine antagonist

dopamine receptor, D2

drug abuse

drug abuse, neurologic complications of

drug induced neurologic disorders

drug interactions

drug overdose

drug withdrawal

dural arteriovenous malformation

dyskinesia, drug induced

dystonia musculorum deformens

dystonia, cervical

dystonia, children

dystonia, drug induced

dystonia, etiology of

dystonia, focal

dystonia, painful

dystonia, psychogenic

dystonia, segmental

dystonia, treatment of

DYT1 mutation

efficacy

electroencephalogram

electroencephalogram, abnormalities of

electron microscopy

emergencies, neurologic

encephalitis

encephalitis lethargica

encephalitis, brainstem

encephalitis, episodic

encephalitis, Powassan

encephalitis, viral

encephalopathy

encephalopathy, delayed

encephalopathy, neonatal

encephalopathy, post anoxic

encephalopathy, progressive

enzyme inhibition

enzyme, defect

enzyme, serum

epidemiology of neurology

epistaxis

erectile dysfunction

evidence-based research

executive dysfunction

eye movement, disorders of

facial nerve palsy

facial weakness

failed medical management

fever of unknown origin

fibrinolytic agents

fibrinolytic agents, complications

fingerprint bodies

fistula, arterio-venous, dural

flavivirus

fluency

flushing

follicle stimulating hormone

foot deformity

fourth ventricle, compression

fracture, long bone

frontal behavioral spatial syndrome

frontal lobe, behavior with disease of

frontal lobe, pathologic signs of

frontotemporal dementia, behavioral variant

gammaglobulin therapy, intravenous

gastrostomy

gastrostomy, percutaneous endoscopic

gaze palsy

gaze palsy, horizontal

gaze palsy, supranuclear

genetic neurologic disorders

genetic testing

geographic location

GFAP-IgG

Gilles de la Tourette syndrome

glabellar sign

globus pallidus

globus pallidus focused ultrasound ablation

globus pallidus, lesion of

globus pallidus, lesion of, bilateral

globus pallidus, stimulation

glutamic acid decarboxylase, antibody

grasp reflex

growth hormone

guanfacine

Hallervorden Spatz disease

head injury, brain stem lesion after

head injury, prognosis in

head injury, severe

headache

hearing loss

hemangioma, brainstem

hemorrhagic diathesis

hepatic failure

hepatolenticular degeneration(Wilson's disease)

hepatolenticular degeneration, non-Wilsonian

heralding manifestation

herniation syndromes, intracranial

HLA

hoarseness

human immunodeficiency virus type 1

hummingbird sign

hunger

hydrocephalus

hyperammonemic encephalopathy

hyperbilirubinemia

hyperbilirubinemia, CNS abnormality after

hypotension, neurologic causes of

hypotension, systemic

hypothyroidism

iatrogenic neurologic disorders

inclusion bodies, eosinophilic cytoplasmic

inclusion bodies, intracytopasmic

inclusion bodies, intranuclear

inclusion bodies, location of

incontinence, fecal

inflexibility, mental

insect sting

insomnia

intellectual deficit

intellectual deterioration

intracerebral hemorrhage

intracerebral hemorrhage, causes of

intracerebral hemorrhage, clot evacuation

intracerebral hemorrhage, incidence of

intracerebral hemorrhage, lobar

intracerebral hemorrhage, recurrent

intracerebral hemorrhage, treatment of

intracranial hypotension

intranasal medication

intravenous

iron, brain

Jakob-Creutzfeldt disease

jaundice

Kayser-Fleischer ring

L-dopa, controlled release

L-dopa, delayed treatment in Parkinsonism

L-dopa, drug interactions with and side effects of

L-dopa, enteral infusion, continuous

L-dopa, plasma concentration

L-dopa, potentiators of

leg spasms

leg spasms, painful

lenticular nucleus, lesion of

lenticular nucleus, lesion of, bilateral

leukoencephalopathy

level of consciousness, decreased

Lewy body

Lewy body disease, diffuse

liver function enzymes

lobar atrophy

logopenia

loss of sympathy

lumbar puncture, complications of

luteinizing hormone

madopar

malformation, vascular

malformation, vascular, cerebral

manganese intoxication

marche a petits pas

masked facies

medical-legal aspects of neurology

medication withdrawal

memory, defect of recent

memory, impairment of

meningeal enhancement

meningismus

meningitis

meningoencephalitis

meningoencephalomyelitis

mental status, abnormal

metabolic acidosis

methcathinone

micrographia

microhemorrhage, intracerebral

microsurgery

microsurgery, transsphenoidal

minimally invasive surgery

misdiagnosis

molecular genetics

monoamine oxidase inhibitors

movement disorder, drug induced

movement disorder, extrapyramidal

movement disorder, psychogenic

movement disorder, treatment of

MRI, angiography, false negative

MRI, contrast enhanced

MRI, diffusion weighted

MRI, disappearing lesion on

MRI, eye of tiger sign

MRI, gradient-echo

MRI, high signal intensity of basal ganglia

MRI, incidental finding

MRI, mass effect on

MRI, negative

MRI, paramagnetic effect

MRI, ring sign

MRI, serial

MRI, susceptibility weighted

MRI, T1 weighted high signal foci

MRI, venography

multiple sclerosis

multiple sclerosis, misdiagnosis

multiple system atrophy

neoplasm, metastatic to CNS

neoplasm, metastatic to CNS, hemorrhagic

neoplasm, metastatic to CNS-hemorrhage into

neoplasm, metastatic to CNS-multiple

neoplasm, metastatic to CNS-prognosis of

neoplasm, metastatic to CNS-treatment of

neoplasm, pituitary

neoplasm, pituitary, treatment of

neoplasm, primary of CNS

neoplasm, primary of CNS-hemorrhage in

neurodegeneration with brain iron accumulation

neuroendocrinology

neurofilament light chain protein

neurofilaments

neuroleptic

neuroleptic malignant syndrome

neuroleptic, atypical

neurologic complications of, surgery

neurologic consultation

neurologic disease

neurologic disease, diagnoses of

neurologic disease, tempo

neurologic examination, focal

neurologic signs

neurologic symptoms

neuronal ceroid-lipofuscinosis

neuronal intranuclear inclusion disease

neuronopathy, sensory

neuroophthalmology

neuropathology

neuropathology, brain

neuropathy

neuroprotective agents

neurotoxic

neurotoxin

New England

obsessive-compulsive disorder

occupational neurologic disorders

octreotide

ocular motility, disorders of

oculogyric crisis

olanzapine

old age, neurology of

ophthalmoplegia

ophthalmoplegia, progressive external

ophthalmoplegia, total

opsoclonus

orthostatic hypotension

outcome research

owl's eye sign of spinal cord

pain

pain, increased response

Parkinson disease, atypical

Parkinson disease, benign tremulous

Parkinson disease, dementia with

Parkinson disease, diagnosis

Parkinson disease, diet restricted in protein

Parkinson disease, differential diagnosis of

Parkinson disease, drug induced

Parkinson disease, duration

Parkinson disease, early symptoms

Parkinson disease, etiology of

Parkinson disease, familial

Parkinson disease, fluctuations in

Parkinson disease, freezing phenomena in

Parkinson disease, intractable

Parkinson disease, late onset

Parkinson disease, L-dopa nonresponsive

Parkinson disease, misdiagnosis

Parkinson disease, mode of onset

Parkinson disease, nonmotor problems of

Parkinson disease, on-off phenomena in

Parkinson disease, pathogenesis of

Parkinson disease, postencephalitic

Parkinson disease, prognosis of

Parkinson disease, progression

Parkinson disease, psychogenic

Parkinson disease, rapid progression

Parkinson disease, sensory symptoms in

Parkinson disease, surgical treatment of

Parkinson disease, transient

Parkinson disease, treatment of

Parkinson disease, unilateral

Parkinson disease, wearing off

Parkinson disease, young onset

Parkinsonism multiple-system atrophy

Parkinsonism syndrome

Parkinsonism, freezing phenomena in

Parkinsonism-dementia complex

pathology

patient information and support

penicillamine

pergolide

persistent vegetative state

personality change

phenothiazine

PHNO

PHNO, enteral infusion, continuous

pituitary, enlargement

pituitary, hormones of

pituitary, microadenoma

pleocytosis of cerebrospinal fluid

POLG1 gene

polyneuropathy

polypharmacy

polyps, gastrointestinal tract

portal caval shunt

posterior fossa, lesion of

posterior fossa, mass of

prevention of neurologic disorders

primary intracranial hypotension

procyclidine

prognosis

progressive neurologic disorder

progressive supranuclear palsy

psychiatric problems in neurologic disorders

psychomotor retardation

pupil, dilated, bilateral

putamen, lesion of

putamen, lesion of, bilateral

pyramidal tract dysfunction

pyridoxine

quality of life

quetiapine

radiation therapy, CNS treatment and complications with

radiation therapy, stereotactic

radioimmunoassay

rapidly progressing neurologic illness

rasagiline

reaction time

reading disorder, acquired

reading problem, causes of

reserpine and reserpine like drugs

respirations in CNS disease

respiratory failure

retina, abnormal

retinitis pigmentosa

reversible neurologic disorder

risk-benefit assessment

risperidone

rodents

ropinirole

ropinirole, prolonged release

Russia

saccadic eye movements

saccadic eye movements, abnormal

safety

sagging of the brain

salivation, excessive

scoliosis

season

sedimentation rate, elevated

seizure

seizure, intractable

selective serotonin reuptake inhibitors

serologic testing

serotonin

serotonin syndrome

serum glutamic oxaloacetic transaminase

serum glutamic pyruvic transaminase

single photon emission computed tomography

skin, biopsy

sleep apnea, obstructive

sleep pathology and physiology

smell

SNCA duplication

somatostatin analogue

somnolence

speech disorder

speech disorder, childhood

speech, soft

spinal cord, lesion of

spinocerebellar ataxia type 1

sports medicine, neurology of

standing difficulty

stare

stem cell transplantation

stereotaxic surgery

stereotyped behavior

steroid

steroid therapy, CNS treatment and complications with

stiff man syndrome

stimulant drugs

stimulation, deep brain

stimulation, deep brain, bilateral

stimulation, sensory

stress, emotional

striatonigral degeneration

stridor

subarachnoid hemorrhage

subdural hematoma

subdural hematoma, acute

substantia nigra

substantia nigra tissue

subthalamic nucleus

subthalamic nucleus deep brain stimulation

suicide

sweating

symmetric brain lesions

systemic lupus erythematosus

systemic lupus erythematosus, neurologic complications with

temporal lobe, atrophy

term infant

thalamotomy

thalamus, focused ultrasound ablation

thalamus, lesion of

thalamus, lesion of-bilateral

tic

tic, classification of

tick-borne encephalitis

toe walking

tolcapone

tonic foot response

tonsillar herniation of cerebellum

toxoplasmosis, CNS

tracheostomy

treatment of neurologic disorder

tremor, surgical treatment of

tremor, thalamic stimulation for suppression of

tremor, treatment of

tremulousness

tricyclic antidepressant

trientine dihydrochloride

trigeminal neuralgia

tripping

twins

tyrosine hydroxylase deficiency

ultrasonography

ultrasonography, head

Unified Parkinson Rating Scale

ventricular obstruction

vision, failure of in childhood

visual acuity, decreased

visual field defect

visual impairment

visual loss

visual loss, progressive

visual loss, slow

visuospatial disturbance

walking, difficulty with

weakness

weakness, progressive

white matter disease, periventricular

word-finding difficulty

workup

Showing articles 50 to 100 of 5828 << Previous Next >>

Diagnosis and Treatment of Psychogenic Parkinsonism
JNNP 82:1300-1303, Jankovic, J., 2011

Pallidal Versus Subthalamic Deep-Brain Stimulation for Parkinsons Disease
NEJM 362:2077-2091, Pollett,K.A., et al, 2010

A Meta-Regression of the Long-Term Effects of Deep Brain Stimulation on Balance and Gait in PD
Neurol 75:1292-1299, St. George,R.J.,et al, 2010

What Predicts Mortality in Parkinson Disease? A Prospective Population-Based Long-Term Study
Neurol 75:1270-1276, Forsaa,E.B.,et al, 2010

Tourettes Syndrome
NEJM 363:2332-2338, Kurlan,R., 2010

Long-Term Effects of Pallidal Deep Brain Stimulation in Tradive Dystonia
Neurol 73:53-58, Gruber,D.,et al, 2009

A 23-Year-Old Man With Seizures and Visual Deficit
Neurol 70:73-78, Boustany,R.-M.,et al, 2008

Dementia and Survival in Parkinson Disease: A 12-Year Population Study
Neurol 70:1017-1022, Buter,T.C.,et al, 2008

A Parkinsonian Syndrome in Methcathinone Users and the Role of Manganese
NEJM 358:1009-1017, Stepens,A.,et al, 2008

Invited Article: Changing Concepts in Parkinson Disease: Moving Beyond the Decade of the Brain
Neurol 70:1996-2003, Marras,C. &Lang,A., 2008

Serum Uric Acid and Clinical Progression in Parkinson Disease: Potential Biomarker for Nigrostriatal Failure
Arch Neurol 65:698-699, Schiess,M. &Oh,I., 2008

Fourteen-Year Final Report of the Randomized PDRG-UK Trial Comparing Three Treatments in PD
Neurol 71:474-480.470, Katzenschlager,R.,et al., 2008

Bilateral Basal Ganglia Lesions in Patients with End-Stage Diabetic Nephropathy
Nephrology 13:68-72, Li, J.,et al, 2008

Wilson Disease: Description of 282 Patients Evaluated Over 3 Decades
Medicine 86:112-121, Taly,A.B., et al, 2007

CNS Lupus: A Study of 41 Patients
Neurol 69:644-654, Joseph,F.G.,et al, 2007

Ropinirole 24-Hour Prolonged Release: Randomized, Controlled Study in Advanced Parkinson Disease
Neurol 68:1108-1115, Pahwa,R.,et al, 2007

Long-Term Outcome of Bilateral Pallidal Deep Brain Stimulation for Primary Cervical Dystonia
Neurol 68:457-459, Hung,S.W.,et al, 2007

Long-term Outcome of Bilateal Pallidal Deep Brain Stimulation for Primary Cervical Dystonia
Neurol 68:457-459, Hung,S.W.,et al, 2007

Is DBS-STN Appropriate to Treat Severe Parkinson Disease in an Elderly Population?
Neurol 68:1345-1355, Derost,P.-P.,et al, 2007

Acromegaly
NEJM 355:2558-2573, Melmed,S., 2006

Practice Parameter: Treatment of Parkinson Disease with Motor Fluctuations and Dyskinesia (An Evidence-Based Review)
Neurol 66:983-995, Pahwa,R.,et al, 2006

Practice Parameter: Diagnosis and Prognosis of New Onset Parkinson Disease (An Evidence-Based Review)
Neurol 66:968-975, Suchowersky,O.,et al, 2006

A Randomized Trial of Deep-Brain Stimulation for Parkinsons Disease
NEJM 355:896-908, Deuschl,G.,et al, 2006

Clinicopath Conf, Dopamine-Responsive-Dystonia Caused by a Mutation in the GCH1 Gene
NEJM 355:831-839, Case 26-2006, 2006

Atypical Antipsychotics in the Elderly with Parkinson Disease and the "Black Box" Warning
Neurol 67:564-566, Friedman,J.H., 2006

Pallidal Deep-Brain Stimulation in Primary Generalized or Segmental Dystonia
NEJM 355:1978-1990, Kupsch,A.,et al, 2006

Benign Tremulous Parkinsonism
Arch Neurol 63:354-357,321, Josephs,K.A.,et al, 2006

The Serotonin Syndrome
NEMJ 352:1112-20, Boyer, E.W. & Shannon, M., 2005

Rasagiline as an Adjunct to Levodopa in Patients With Parkinsons Disease and Motor Fluctuations (LARGO, Lasting Effect in Adjunct Therapy With Rasagiline Given Once Daily, Study)
Lancet 365:947-954, 914, Rascol,O., et al, 2005

A Randomized Placebo-Controlled Trial of Rasagiline in Levodopa-Treated Patients with Parkinson Disease and Motor Fluctuations
Arch Neurol 62:241-248, The PRESTO Study, 2005

Post-Stroke Movement Disorders; Report of 56 Patients
JNNP 75:1568-1574, Alarcon,F.,et al, 2004

Clinical Features and Natural Histry of Progressive Supranuclear Palsy, A Clinical Cohort Study
Neurol 60:910-916, Nath,W.,et al, 2003

Neuropsychological and Quality of Life Outcomes 12 Months After Unilateral Thalamic Stimulation for Essential Tremor
JNNP 74:305-311, Fields,J.A.,et al, 2003

Neurologic Manifestations and Outcome of West Nile Virus Infection
JAMA 290:511-515,524,558, Sejvar,J.J.,et al, 2003

Five-Year Follow-up of Bilateral Stimulatioin of the Subthalamic Nucleus in Advanced Parkinson's Disease
NEJM 349:1925-1934,1888, Krack,P.,et al, 2003

Awakenings From Persistent Vegetative State: Report of Three Cases With Parkinsonism and Brain Stem Lesions on MRI
JNNP 74:1571-1573, Matsuda,W.,et al, 2003

Long-Term Follow-Up of Thalamic Deep Brain Stimulation for Essential and Parkinsonian Tremor
Neurol 61:1601-1604, Kumar,R.,et al, 2003

Parkinson Disease With Old-Age Onset
Arch Neurol 60:529-533, Diederich,N.J.,et al, 2003

Bilateral Subthalamic Nucleus Stimulation Improves Health-Related Quality of Life in PD
Neurol 59:1976-1978, Lagrange,E.,et al, 2002

Deep Brain Stimulation in the Treatment of Parkinson's Disease,A Cost-Effectiveness Analysis
Neurol 57:663-671, Tomaszewski,K.J.&Holloway,R.G., 2001

A randomized,Double-blind,Placebo-Controlled Trial of Subcutaneously Injected Apomorphine for Parkinsonian Off-State Events
Arch Neurol 58:1385-1392, Dewey,R.B.,et al, 2001

Ten-year Follow-up of Three Different Initial Treatments in De-novo PD
Neurol 57:1687-1694, Lees,A.J.,et al, 2001

What Contributes to Quality of Life in Patients with Parkinson's Disease?
JNNP 69:308-312,289, Schrag,A. et al, 2000

Long-Term Follow-Up of Unilateral Pallidotomy in Advanced Parkinson's Disease
NEJM 342:1708-1714, Fine,J.,et al, 2000

Functional Outcomes After Gamma Knife Thalamotomy for Essential Tremor and MS-Related Tremor
Neurol 55:443-446, Niranjan,A. et al, 2000

Health-Related Quality of Life in Neurology
Arch Neurol 57:1224-1227, Meyers,A.R. et al, 2000

Selegiiline and Mortality in Subjects with Parkinson's Disease
Neurol 55:1785-1789,1770, Donnan,P.T.,et al, 2000

Mortality Cancer Risk in Parkinsonian Patients:A Population-Based Study
Neurol 52:395-398, Vanacore,N.,et al, 1999

Long-Term Evaluation of Bilateral Fetal Nigral Transplantation in Parkinson Disease
Arch Neurol 56:179-187, Hauser,R.A.,et al, 1999

Efficacy, Safety, and Tolerance of the Non-Ergoline Dopamine Agonist Pramipexole in the Treatment of Advanced Parkinson's Disease:A Double Blind, Placebo Controlled, Randomised, Multicentre Study
JNNP 66:436-441, Pinter,M.M.,et al, 1999

Showing articles 50 to 100 of 5828 << Previous Next >>